These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21245814)

  • 1. [Assessment of erythrocyte sedimentation rate (ESR) and C- reactive protein (CRP) on rheumatoid arthritis activity prediction].
    Silva I; Mateus M; Branco JC
    Acta Reumatol Port; 2010; 35(5):456-62. PubMed ID: 21245814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Wolfe F
    J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values.
    Inoue E; Yamanaka H; Hara M; Tomatsu T; Kamatani N
    Ann Rheum Dis; 2007 Mar; 66(3):407-9. PubMed ID: 16926186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative sensitivity to change of the erythrocyte sedimentation rate and serum C-reactive protein concentration in rheumatoid arthritis.
    Ward MM
    J Rheumatol; 2004 May; 31(5):884-95. PubMed ID: 15124246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
    Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
    J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis.
    Dessein PH; Joffe BI; Stanwix AE
    J Rheumatol; 2004 Jun; 31(6):1095-7. PubMed ID: 15170920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.
    Sokka T; Pincus T
    J Rheumatol; 2009 Jul; 36(7):1387-90. PubMed ID: 19411389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
    J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.
    Mallya RK; de Beer FC; Berry H; Hamilton ED; Mace BE; Pepys MB
    J Rheumatol; 1982; 9(2):224-8. PubMed ID: 7097681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
    Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
    J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
    Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis.
    Yildirim K; Karatay S; Melikoglu MA; Gureser G; Ugur M; Senel K
    Ann Clin Lab Sci; 2004; 34(4):423-6. PubMed ID: 15648784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
    Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
    Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S; Priyanka BU
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.
    Emlen W; Niebur J; Flanders G; Rutledge J
    J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting.
    Nordal EB; Zak M; Aalto K; Berntson L; Fasth A; Herlin T; Lahdenne P; Nielsen S; Peltoniemi S; Straume B; Rygg M
    Ann Rheum Dis; 2012 Jul; 71(7):1122-7. PubMed ID: 22258487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
    Ban A; Inaba M; Furumitsu Y; Okamoto K; Yukioka K; Goto H; Nishizawa Y
    Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis.
    de Man YA; Hazes JM; van de Geijn FE; Krommenhoek C; Dolhain RJ
    Arthritis Rheum; 2007 Jun; 57(5):716-22. PubMed ID: 17530669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amyloid A in the assessment of early inflammatory arthritis.
    Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
    J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
    Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
    Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.